<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33106391</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>05</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Differential Neuropsychological Profile of Patients With Amyotrophic Lateral Sclerosis With and Without <i>C9orf72</i> Mutation.</ArticleTitle><Pagination><StartPage>e141</StartPage><EndPage>e152</EndPage><MedlinePgn>e141-e152</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000011093</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine whether the neuropsychological profiles of patients with amyotrophic lateral sclerosis (ALS) with (ALSC9+) and without (ALSC9-) <i>C9orf72</i> expansion are different, we administered a battery of neuropsychological tests to 741 patients with ALS (68 ALSC9+ and 673 ALSC9-) and 129 controls.</AbstractText><AbstractText Label="METHODS">The study population includes 741 patients with ALS who were consecutively diagnosed at the Turin ALS expert center in the 2010-2018 period and who underwent both cognitive/behavioral and genetic testing. Patients' neuropsychological patterns were compared (1) at the same degree of cognitive and behavioral deficit according to the revised ALS-Frontotemporal Dementia Consensus Criteria and (2) at the same level of motor impairment according to the King staging system.</AbstractText><AbstractText Label="RESULTS">Despite being about 7 years younger, ALSC9+ patients had significantly lower scores in tests exploring executive function and verbal memory both when classified as cognitively normal and when diagnosed in the intermediate cognitive categories. Considering the clinical perspective, ALSC9+ patients showed significantly lower scores compared to ALSC9- patients at King stage 1 and 3 in almost all the examined neuropsychological domains; at King stage 2, ALSC9+ patients were more severely affected only in the verbal memory domain. Behavioral function was comparably impaired in the 2 cohorts.</AbstractText><AbstractText Label="CONCLUSIONS">ALSC9+ patients show a different neuropsychological profile compared to ALSC9- patients, being more impaired in executive functions and verbal memory domains at all King stages. Verbal memory emerged as a particularly vulnerable function in ALSC9+, with worse performances even when patients were still classified as cognitively normal.</AbstractText><CopyrightInformation>&#xa9; 2020 American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iazzolino</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peotta</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zucchetti</LastName><ForeName>Jean Pierre</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canosa</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manera</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grassano</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palumbo</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunetti</LastName><ForeName>Maura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barberis</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sbaiz</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moglia</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9579-5341</Identifier><AffiliationInfo><Affiliation>From the ALS Center, 'Rita Levi Montalcini' Department of Neuroscience (B.I., L.P., J.P.Z., A. Canosa, U.M., R.V., M.G., F.P., M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), University of Torino; Medical Genetic Unit (M. Barberis, L.S.) and Neurology 1 (A. Canosa, M. Brunetti, C.M., A. Calvo, A. Chi&#xf2;), Azienda Ospedaliero-Universitaria Citt&#xe0; della Salute e della Scienza of Torino, Turin; and Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;), National Research Council, Rome, Italy. achio@usa.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>27</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33106391</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000011093</ArticleId><ArticleId IdType="pii">WNL.0000000000011093</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>